Copeptin as a dual biomarker in type 2 diabetes: association with glycemic control and diabetic kidney disease

Bibliographic Information
Authors: Rakha N.K.; Fayed A.; Ramiz S.A.; ElSayed E.; Al-Dawy S.A.; Bolis F.M.; Fathy A.; Abouzeid S.; Darwish R.A.; Gomaa M.; Elsheimy H.A.
Journal: BMC Endocrine Disorders
Publisher: BioMed Central Ltd
Publication Date: 19 February 2026
Volume / Issue: Volume 26 / Issue 1
Article No.: 85
ISSN: 14726823
DOI: 10.1186/s12902-026-02182-5
Scopus: View on Scopus
PubMed: 41715079
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Rakha N.K., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Fayed A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt, Cairo University Hospitals, Al-Saray St., El-Maniel, Cairo, 11562, Egypt; Ramiz S.A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; ElSayed E., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Al-Dawy S.A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Bolis F.M., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Fathy A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Abouzeid S., Nephrology Department, Theodor Bilharz Research Institute, Cairo, Egypt; Darwish R.A., Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Gomaa M., Endocrinology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt; Elsheimy H.A., Endocrinology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt
Abstract
Background: Chronic kidney disease and end-stage renal disease are significantly contributed by diabetes mellitus (DM), especially diabetes mellitus type 2 (T2DM). A stable surrogate marker of vasopressin, the serum copeptin, has become a potential biomarker of poor glycemic control and diabetic kidney disease (DKD). The research objective is to estimate the usefulness of the serum copeptin as a marker of glycemic status and its correlation with DKD in patients with T2DM. Methods: This cross-sectional study was conducted on 60 participants at Cairo University Hospital between 2021 and 2022. Participants were divided into 40 T2DM patients (26 males, 14 females; mean age 52.62 ± 9.7 years) and 20 healthy controls. Diabetic patients were further categorized into controlled (HbA1c ≤ 7%, n = 18) and uncontrolled (HbA1c > 7%, n = 22) subgroups. Clinical evaluation, biochemical tests, and serum copeptin levels (measured via ELISA) were analyzed. Cairo university, Faculty of Medicine, Ethical approval: N-247-2023. Results: Serum copeptin levels were significantly higher in diabetic patients compared to controls (p < 0.001), and in uncontrolled vs. controlled diabetics (p < 0.001). Copeptin positively correlated with fasting glucose, HbA1c, serum creatinine, and urinary protein, and negatively with eGFR. ROC analysis identified copeptin as a sensitive marker for both poor glycemic control at a cut off value > 3452 pg/mL (AUC 0.925) and DKD at a cut off vlue > 370 pg/mL (AUC 0.94), both with high sensitivity and specificity. Conclusion: The level of serum copeptin correlates positively with poor glycemic status as well as DKD among T2DM patients. It can be an effective, non-invasive biomarker used in early diagnosis and risk stratification of diabetic complications. Clinical trial registration: Not applicable. © The Author(s) 2026.
Keywords
Copeptin; Diabetic kidney disease; Glycemic control; Type 2 diabetes; Adult; Biomarkers; Blood Glucose; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Glycated Hemoglobin; Glycopeptides; Humans; Male; Middle Aged; Prognosis; albumin; creatinine; glucose; hemoglobin A1c; sodium; uric acid; biological marker; glycopeptide; albumin blood level; area under the curve; Article; biochemical analysis; blood cell count; clinical article; clinical evaluation; controlled study; correlation analysis; creatinine blood level; cross-sectional study; diabetic nephropathy; diabetic patient; diagnostic accuracy; diagnostic test accuracy study; Egypt; enzyme linked immunosorbent assay; estimated glomerular filtration rate; fasting blood glucose level; glucose blood level; hemoglobin blood level; human; non insulin dependent diabetes mellitus; observational study; predictive value; protein blood level; protein urine level; receiver operating characteristic; sensitivity and specificity; sodium blood level; sodium urine level; university hospital; urea nitrogen blood level; uric acid blood level; blood; case control study; complication; diagnosis; etiology; follow up
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
